viernes, 21 de junio de 2024

FDA updates guidance on interchangeability

https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-guidance-interchangeability?utm_medium=email&utm_source=govdelivery This draft guidance describes considerations regarding a switching study or studies intended to support a demonstration that a biological product is interchangeable with a reference product.

No hay comentarios: